Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

Joint pain and stiffness are common complaints among older adults, with conditions like osteoarthritis, rheumatoid arthritis, ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

A natural antibacterial molecule shows clinical promise. Its unusual binding site is on an excellent target: ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

As interest in these compounds grows, many people are also seeking effective ways to anabolic steroids kaufen to maximize ...

A team of undergraduate researchers has developed an innovative way to produce essential medications more affordably and ...

CordenPharma provides large-scale peptide manufacturing for the Dual GLP-1/GIP Receptor Agonist drug substance of VK2735. CordenPharma provides fill-finish for the drug candidate's subcutaneous ...

CordenPharma provides large-scale peptide manufacturing for the Dual GLP ... CordenPharma & Viking Therapeutics sign long-term integrated supply partnership to support GLP-1 drug candidate VK2735.

CordenPharma provides fill-finish for the drug candidate's subcutaneous formulation and oral solid dosage manufacturing for its oral peptide formulation. CordenPharma & Viking Therapeutics sign ...